Esoteric Testing Market Scope and Key Players Analysis by 2030
Esoteric Testing Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 25,976.97 Million |
Market Size by 2030 | US$ 79,777.20 Million |
Global CAGR (2022 - 2030) | 15.1% |
Historical Data | 2020-2022 |
Forecast period | 2022-2030 |
Segments Covered |
By Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
Industry Developments and Future Opportunities:
Various initiatives taken by key players operating in the esoteric testing market are listed below:
- In March 2022, Waters Corporation launched the Xevo TQ Absolute system, a compact benchtop tandem mass spectrometer. This highly sensitive, latest mass spectrometer quantifies negatively ionizing compounds with up to 15-fold greater sensitivity than its predecessor, with a 45% smaller size and up to 50% less electricity and gas consumption.
- In February 2021, Quest Diagnostics collaborated with Grail for its Galleri multicancer blood tests. Quest Diagnostics had plans to provide phlebotomy services using the Galleri multicancer early-detection blood tests.
Competitive Landscape and Key Companies:
Georgia Esoteric & Molecular Laboratory LLC, Laboratory Corp of America Holdings, Quest Diagnostics Inc., National Medical Services Inc., OPKO Health Inc., ARUP Laboratories Inc., bioMONTR Labs, Athena Esoterix LLC, Stanford Hospital & Clinics, and Foundation Medicine Inc. are among the prominent companies in the esoteric testing market. These companies focus on the introduction of new technologies, upgrading of existing products, and expansion of their geographic reach to meet the growing consumer demand worldwide.